Countdown to 2022 CBIIC：
Vice President of Beroni Group Limited
Dr. Zhenghu Jia is the vice president of Beroni Group, director of Immunology and Microecology Laboratory, Biomedical Translational Research Institute, Jinan University, PI of International Immunization Center, Jinan University, bachelor of Clinical Medicine, Shandong University School of Medicine, master of Immunology and doctor of Nankai University, postdoctoral of the First Affiliated Hospital of Jinan University, visiting scholar of Columbia University and Showa University in Japan. He once served as the director of Wuhan Purui Medical Laboratory, and has nearly ten years of management experience in the research and development of new antitumor drugs and in vitro diagnosis industry. In 2017, he was hired by Beroni Group (OTCQX: BNIGF; NSX: BTG) as the president of Precision Medicine International R&D Center, and was promoted to the Group’s vice president in 2019. During his tenure, he successfully introduced projects such as PENAO, an anti-tumor small molecule drug and DC tumor vaccine. At present, he has participated in 13 multi-center clinical trials nationwide, and has cooperated with third parties for more than 50 medical projects as an initiator. He has won 4 provincial and ministerial awards, has published 10 SCI articles in foreign journals, and has obtained 30 authorized patents. The detection kit which he directed was approved as a key special project by the Ministry of Science and Technology.